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BRIEF COMMUNICATION
Neuroticism and polymorphisms in the serotonin transporter gene
I. J. DEARY," S. BATTERSBY, M. C. WHITEMAN, J. M. CONNOR, F. G. R. FOWKES
and A. HARMAR
From the Department of Psychology, MRC Brain Metabolism Unit and Department of Public Health
Sciences, University of Edinburgh; and Duncan Guthrie Institute of Medical Genetics, University of Glasgow
ABSTRACT
Background. There is evidence for an association between two different polymorphisms of the
human serotonin transporter gene (5-HTT) and the personality trait of neuroticism and affective
disorder.
Methods. We studied the association between neuroticism and polymorphisms in the 5HTT-linked
promoter region and in a variable number tandem repeat region (VNTR) of the 5-HTT gene in 204
people aged over 60 derived from a random sample of men and women in the general population.
Approximately half of the subjects were in the top 20% of neuroticism scorers and half in the
bottom 20%.
Results. There were no significant differences in allelic or genotypic frequencies between the high
and low neuroticism scorers. There was highly significant linkage disequilibrium between the two
5-HTT gene polymorphisms, and haplotype analysis showed no association between neuroticism
level and haplotype.
Conclusions. Reports of an association between two 5-HTT gene polymorphisms and the
personality trait of neuroticism are not supported by these results.
INTRODUCTION
The converging consensus about the number of
principal human personality traits ranges from
between three (Eysenck, 1991) and five (Costa &
McCrae, 1992; Goldberg, 1993) to seven
(Almagor et al. 1995; Cloninger et al. 1993).
Among these models there is much agreement,
especially with regard to two traits (Matthews &
Deary, 1998). First, extraversion is an important,
reliable, stable and valid source of individual
differences with respect to sociability. Secondly,
the broad tendency to experience negative
emotions is described in the dimension of
neuroticism.
Neuroticismhas appeared as a clear dimension
within self- and peer-reports of personality since
" Address for correspondence: Professor Ian J. Deary, Department
of Psychology, University of Edinburgh, 7 George Square, Edinburgh
EH8 9JZ.
the beginnings of scientific research on per-
sonality (Deary, 1996). Neuroticism appears in
most systems of personality traits and also in
disparate cultures (Barrett & Eysenck, 1984).
Individual differences in neuroticism are highly
stable across many years in adulthood (Conley,
1985). High neuroticism predisposes people to
clinical depression and affects the time to relapse
in people who are already depressed (Surtees &
Wainwright, 1996). Neuroticism has a large
effect on self-reports of physical health and the
experience of functional (medically unexplained)
symptoms (Kirmayer et al. 1994).
What are the biological bases of neuroticism?
One suggestion was that people high in neur-
oticism have greater reactivity of the autonomic
nervous system (Eysenck, 1967). This suggestion
has proved difficult to confirm or refute
(Zuckerman, 1991). The main evidence for a
biological basis for neuroticism comes from
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heritability studies. Family, twin and adoption
studies indicate that about 27–31% of the
variance in neuroticism is accounted for by
additive genetic variance, and a further 14–17%
by non-additive genetic variance (Loehlin, 1992).
Neuroticism appears to be a genetic risk factor
for anxiety and depressive disorders (Jardine et
al. 1984).
The link between neuroticism and affective
disorder suggests that the serotonin (or 5-
hydroxytryptamine or 5-HT) neurotransmitter
systemmight make a contribution to neuroticism
differences. Functioning of this system is altered
in depression, and antidepressant drugs act
upon it (Ogilvie & Harmar, 1997). Newer
antidepressant drugs are serotonin specific re-
uptake inhibitors. Thus, the system of pre-
synaptic serotonin reuptake and the serotonin
transporter that is responsible for 5-HT reuptake
might be implicated in neuroticism differences.
The human serotonin transporter is encoded by
a single gene on chromosome 17q11.1–17q2
(Ramamoorthy et al. 1993; Ogilvie & Harmar,
1997). It spans approximately 31 kb and com-
prises 14 exons.
Information about biological mechanisms
underlying personality differenes can come from
molecular genetic methods, especially the tech-
nique of quantitative trait loci (QTL; Plomin et
al. 1994). Phenotypic characteristics often have
multiple genetic determinants and the percentage
of variance in the phenotype accounted for by
the action of any one site of genetic variability
might be small. In QTL as applied to personality
research, candidate genes should have two
features. First, the candidate gene should have
some prima facie relevance to the personality
dimension in question. Secondly, the gene in
question should show polymorphism; that is, it
should show variability in the population. These
characteristics are met by two recently-described
polymorphisms in the serotonin transporter gene
(5-HTT; Ogilvie & Harmar, 1997).
The first polymorphism is in the 5-HTT-
linked promoter region (5-HTTLPR; Heils et al.
1996). It involves a 44 base-pair insertion}
deletion. Decreased serotonin transporter ex-
pression is associated with the short form of the
allele. Having single or double copies of the
short form accounted for about 4% of the
variance in neuroticism (Lesch et al. 1996).
However, subsequent reports failed to replicate
the association (Ball et al. 1997; Ebstein et al.
1997). The short form has been associated with
affective disorder (Collier et al. 1996) but this
was not replicated in a subsequent report (Rees
et al. 1997).
The second relevant polymorphism of the 5-
HTT gene is a variable number tandem repeat
region (VNTR) within the second intron (Ogilvie
& Harmar, 1997), containing variable numbers
of copies of a 16–17 base-pair element. The three
alleles contain 9, 10 and 12 repeats. People with
a history of unipolar depression are about four
times more likely to carry the allele with nine
copies of the repeated element (Battersby et al.
1996; Harmar et al. 1996; Ogilvie et al. 1996).
One study (Stober et al. 1996) failed to find an
association between the uncommon nine repeat
allele and affective disorder, whereas a second
suggested a weak association with unipolar
disorder (Rees et al. 1997). The 12 repeat allele
might be more common in people with manic
depressive disorder (Collier et al. 1996, Kunugi
et al. 1997; Rees et al. 1997). A study of German
twins found no association between the 12
repeat allele and self- and peer-reported neur-
oticism (Ball et al. 1997).
In the present study we report the association
between the above two polymorphisms in the
serotonin transporter gene – 5-HTTLPR and
VNTR – and self-report neuroticism levels in a




Participants were members of the Edinburgh
Artery Study, a randomly selected sample of 809
men and 783 women in the general population
in Edinburgh, aged 55–74 years at recruitment
in 1988 (Fowkes et al. 1991). Participants were
sampled from age-sex registers of general
practices. A follow-up examination took place
between November 1992 and March 1994, when
blood was taken for genetic analyses.
NEO-Five Factor Inventory (NEO-FFI; Costa
& McCrae, 1992)
Subjects completed the NEO-FFI, a self-report
personality instrument that measures personality
factors of neuroticism, extraversion, openness,
agreeableness and conscientiousness. Only neur-
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oticism was studied with respect to the two
variations in the serotonin transporter gene. The
NEO-FFI was sent to all surviving members of
the cohort who were still participating and
contactable between March 1995 and November
1995. There had been 269 (17%) deaths, 27
(1–6%) were no longer participating in the
study, and 20 (1–3%) participants were not
traceable. There were, therefore, 1196 eligible
participants, and 1028 personality question-
naires were received (86% response rate). Of
these, 901 had valid neuroticism scores (75%).
A small proportion (16%, 189 subjects) filled in
their questionnaires at a university clinic, the
remainder at home.
For the genetic analyses the top and bottom
150 scorers on neuroticism were chosen. An
additional 60 from each extreme were identified
to be used as substitutes. Blood samples were
sent to the MRC Brain Metabolism Unit,
Edinburgh, for genotyping. Not all participants
with valid neuroticism scores had viable blood
samples, and the final groups for analysis
contained 100 high and 104 low neuroticism
scorers. The range of the neuroticism scores in
the top group was 23–47, and in the bottom
group 0–12. Therewere 259 (92 men, 167women)
who fell into the top range of scores, and the
final sample was, therefore, 39% (38 men, 62
women) of them. In the low scoring group there
were 171 (109 men, 62 women) people, and the
sample represented 61% (66 men and 38 women)
of them.
Genotyping
During the 1992–1994 clinic visit, 30 ml of
venous blood was withdrawn. A tourniquet was
used but released as quickly as possible. A 10 ml
genetic sample, placed in an EDTA tube and
inverted 5 or 6 times, was stored in a 4 °C
refrigerator and then posted to the Duncan
Guthrie Institute of Medical Genetics, Glasgow.
DNA was extracted from lymphocytes using
standard techniques (Kunkel et al. 1977).
Amplification of the VNTR region in intron 2
of the HSERT gene was carried out as described
previously (Battersby et al. 1996). For the 5-
HTTLPRpolymorphism PCRamplification was
carried out using forward primer 5«-CACCTA-
ACCCCTAATGTCCCTACT and reverse
primer 5«-GGACTGAGCTGGACAACCAC in
a reaction volume of 50 ll. The mixture con-
tained 1‹Pfu buffer (Stratagene), 100 ng of
each primer, 1 ll of a 1 in 10 dilution of DNA,
200 lm each of dATP, dCTP and dTTP, together
with 100 lm- dGTP and 100 lm 7-deaza-GTP.
The reaction was heated to 98 °C for 5 min and
2–5 U Pfu exo-minus polymerase (Stratagene)
was added in 5 ll of 1‹Pfu buffer. Amplification
consisted of 40 cycles of 98 °C for 45 s, 65 °C for
45 s, and 72 °C for 90 s, with a final extension
for 5 min at 72 °C. Products were resolved on
3% agarose gels and visualized by ethidium
bromide staining under UV transillumination.
RESULTS
The 5-HTTLPR serotonin transporter marker’s
allelic (v#fl 0–00, dffl 1, NS) and genotypic
(v#fl 2–44, dffl 2, NS) frequencies were similar
in the low and high neuroticism groups (Table
1a). In addition, the 5-HTT VNTR serotonin
transporter marker’s allelic (v#fl 0–86, dffl 2,
NS) and genotypic (v#fl 2–22, dffl 5, NS)
frequencies were similar in the high and low
neuroticism groups (Table 1b).
Maximum likelihood estimates of haplotype
distributions in the total population and in
the high and low neuroticism groups were
made and compared with the Arlequin soft-
ware package (Schneider et al. 1996). There
was highly significant linkage disequilibrium
between 5-HTTLPR and VNTR polymorphisms
(P! 0–0001 for the total sample and the high
neuroticism sample, and P! 0–02 in the low
neuroticism sample), with allele 9 of the VNTR
associated exclusively with the long form of the
5-HTTLPR and a progressive increase in fre-
quency of haplotypes containing the short form
of the 5-HTTLPR with increasing number of
repeats in the VNTR. However, there was no
evidence for any association between haplotype
and neuroticism.
DISCUSSION
The present study did not find support for an
association between self-reported neuroticism
score and two polymorphisms on the human
serotonin transporter gene. Compared with
other published studies on this topic the present
study is large and involved a normal sample of
the older population. This negative result is
unlikely to be due to sample size ; we had a
power of 80% to detect an effect at a significance
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Table 1. Allelic and genotypic frequencies for the (a) 5-HTTLPR and (b) 5-HTT VNTR
serotonin transporter marker in groups with high and low NEO-FFI neuroticism scores
(a)
Allelic frequency Genotypic frequency
S L SS SL LL
High neuroticism 0–456 0–544 0–235 0–441 0–324
Low neuroticism 0–455 0–545 0–180 0–550 0–270
(b)
Allelic frequency Genotypic frequency
9 10 12 9–9 9–10 9–12 10–10 10–12 12–12
High neuroticism 0–035 0–353 0–611 0–010 0–030 0–020 0–131 0–414 0–394
Low neuroticism 0–024 0–329 0–648 0–000 0–019 0–029 0–095 0–448 0–410
level of 0–05. The closest comparable study is
that of Ball et al. (1997). Their study of
individuals from a German twin sample
examined the top and bottom 5% of neuroticism
scorers on the NEO-FFI. They suggested that a
wider range of the population distribution
should be tested in case the 5-HTT genes were
associated with the normal range of neuroticism
but not the extremes. No evidence of this may be
found in the present study. The other negative
study of personality traits and a 5-HTT related
gene was that by Ebstein et al. (1997) in which
TPQ harm avoidance showed no relationship
with 5-HTTLPR allelic and genotypic variation
in over 120 normal subjects.
There remain some substantial positive
findings. The association of the short form of
the 5-HTTLPR gene and neuroticism and
anxiety traits in a large sample (Lesch et al.
1996), and the possibility that affective disorder
is related to the 9 and}or the 12 repeat alleles of
the VNTR gene (Collier et al. 1996; Harmar et
al. 1996) remain to be replicated or refuted. The
importance of further studies lies in the wide
publicity that the original, positive results have
received (Craddock, 1996; Goldman, 1996; Eley
& Plomin, 1997; Ogilvie & Harmar, 1997).
Further attempts at replications of recent
findings with respect to genes and personality
traits and mood disorders will clarify the current
contradictory account. In addition, it will be
interesting to investigate new candidate genes as
they appear. In addition to research on humans,
leads may be expected from some animal models
of human personality traits and mood disorders,
such as the research that has shown that
individual differences in ‘emotionality ’ in mice
are influenced by loci on murine chromosomes
1, 12 and 15 (Flint et al. 1995).
We thank: the people involved in the Edinburgh
Artery Study, especially the General Practitioners ;
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